Current and emerging treatment options for uterine fibroids

M Ali, M Ciebiera, M Wlodarczyk, S Alkhrait, E Maajid… - Drugs, 2023 - Springer
Uterine fibroids are the most common benign neoplasm of the female reproductive tract in
reproductive age women. Their prevalence is age dependent and can be detected in up to …

The impact of fibroid treatments on quality of life and mental health: a systematic review

B Neumann, B Singh, J Brennan, J Blanck, JH Segars - Fertility and sterility, 2024 - Elsevier
Fibroids significantly impact the quality of life (QOL) and mental health of affected women.
However, there are limited comparative data on QOL measures after medical, surgical, and …

Contemporary approaches in the management of uterine leiomyomas

S Singh, P Kumar, SS Rathore, Y Singh… - European Journal of …, 2023 - Elsevier
Background Leiomyomas (fibroids), the most common benign solid tumours in females,
originate from the myometrium and are associated with poor quality of life for patients. The …

[HTML][HTML] LIBERTY randomized withdrawal study: relugolix combination therapy for heavy menstrual bleeding associated with uterine fibroids

A Al-Hendy, R Venturella, JCA Ferreira, Y Li… - American Journal of …, 2023 - Elsevier
Background In the pivotal LIBERTY 1 and 2 trials and long-term extension study, once-daily
relugolix combination therapy (40 mg relugolix, 1 mg estradiol, 0.5 mg norethindrone …

Quality of life improvements in women with uterine fibroids treated with relugolix combination therapy during the LIBERTY long‐term extension study: a descriptive …

R Venturella, AS Lukes, R Wu… - … of Gynecology & …, 2024 - Wiley Online Library
Objective To investigate the effects of 52 weeks of treatment with relugolix combination
therapy (relugolix 40 mg, estradiol 1 mg, norethindrone acetate 0.5 mg) on symptoms of …

Medical Management of Heavy Menstrual Bleeding.

DF Archer - Magyar Nőorvosok Lapja, 2024 - search.ebscohost.com
Heavy menstrual bleeding (HMB) is a common symptom in women accounting for 30% of
Physician office visits. HMB is associated with a wide range of medical findings from …

It's time to make a change from a lesion-tailored to a patient-tailored approach in the management of uterine fibroids

A Di Spiezio Sardo, A Maiorana, L Muzii… - ITALIAN JOURNAL OF …, 2024 - air.unimi.it
The management of patients with uterine fibroids (UF) has changed substantially during the
last century thanks to the development of new drugs focused on symptom management. The …

[PDF][PDF] Farmácia Ferreira da Silva, Porto e Serviços Farmacêuticos do Hospital Privado da Boa Nova (Grupo Trofa Saúde), Perafita

JMF Magalhães - 2023 - repositorio-aberto.up.pt
Durante 5 anos, todos os estudantes do Mestrado Integrado em Ciências Farmacêuticas
(MICF) da Faculdade de Farmácia da Universidade do Porto (FFUP) percorrem um percurso …

[PDF][PDF] A comparative study on myomectomy and total hysterectomy in the treatment of perimenopausal uterine fibroids.

J Zeng, J Wang, M Wang, X Wang - European Journal of …, 2024 - oss.ejgo.net
This study aims to compare the clinical efficacy of myomectomy and total hysterectomy in the
treatment of perimenopausal uterine fibroids. 124 cases of uterine fibroids were randomly …

Relugolix-Kombinationstherapie bei Uterusmyomen

F Lichert - Frauenheilkunde up2date, 2023 - thieme-connect.com
Symptomatische Uterusmyome können für die betroffenen Patientinnen eine große
Belastung darstellen und zu einer negativen Beeinflussung des täglichen Lebens sowie der …